N-Deacetylthiocolchicine
N-Deacetylthiocolchicine is a tubulin inhibitor with an IC50 value of 2.2 nM in MDR-negative MDA-MB 231 breast cancer cells. N-Deacetylthiocolchicine exerts antiproliferative activity by binding to tubulin to interfere with microtubule assembly, arresting cells in mitosis during the cell cycle. N-Deacetylthiocolchicine is promising for research of malignancies such as breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 2731-16-0
- Formula: C20H23NO4S
- Molecular Weight:373.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | ED50 |
0.0077 μg/mL
Compound: 4
|
Cytotoxicity against human A549 cells after 2 days
Cytotoxicity against human A549 cells after 2 days
|
[PMID: 20542428] |
| A549 | IC50 |
11 nM
Compound: DTCOLCH
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay
|
[PMID: 34592435] |
| A549 | IC50 |
24.1 nM
Compound: 3
|
Antiproliferative activity against human A549 cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human A549 cells incubated for 72 hrs by SRB assay
|
[PMID: 33465696] |
| BALB/3T3 | IC50 |
15.4 nM
Compound: DTCOLCH
|
Cytotoxicity against mouse BALB/3T3 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against mouse BALB/3T3 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 34592435] |
| BALB/3T3 | IC50 |
223 nM
Compound: 3
|
Antiproliferative activity against mouse BALB/3T3 cells incubated for 72 hrs by SRB assay
Antiproliferative activity against mouse BALB/3T3 cells incubated for 72 hrs by SRB assay
|
[PMID: 33465696] |
| CA46 | IC50 |
38 μM
Compound: 6a
|
Inhibits the growth of the human Burkitt lymphoma CA46 cell
Inhibits the growth of the human Burkitt lymphoma CA46 cell
|
[PMID: 9083485] |
| DLD-1 | IC50 |
1180 nM
Compound: 7
|
Cytotoxicity against human DLD1 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human DLD1 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30429975] |
| DU-145 | ED50 |
0.0018 μg/mL
Compound: 4
|
Cytotoxicity against human DU145 cells after 2 days
Cytotoxicity against human DU145 cells after 2 days
|
[PMID: 20542428] |
| H9 | EC50 |
0.013 μM
Compound: 10
|
Cytotoxicity against human H9 cells
Cytotoxicity against human H9 cells
|
[PMID: 1919593] |
| H9 | IC50 |
0.013 μM
Compound: 10
|
Antiviral activity against HIV1 HTLV-3B in human H9 cells after 3 days by p24 antigen capture assay
Antiviral activity against HIV1 HTLV-3B in human H9 cells after 3 days by p24 antigen capture assay
|
[PMID: 1919593] |
| HCT-8 | ED50 |
0.005 μg/mL
Compound: 4
|
Cytotoxicity against human HCT8 cells after 2 days
Cytotoxicity against human HCT8 cells after 2 days
|
[PMID: 20542428] |
| HeLa | GI50 |
0.014 μM
Compound: 11a
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell number incubated for 72 hrs
Antiproliferative activity against human HeLa cells assessed as reduction in cell number incubated for 72 hrs
|
[PMID: 30996805] |
| HepG2 | GI50 |
0.018 μM
Compound: 11a
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell number incubated for 72 hrs
Antiproliferative activity against human HepG2 cells assessed as reduction in cell number incubated for 72 hrs
|
[PMID: 30996805] |
| IGROV-1 | IC50 |
0.023 μM
Compound: 2
|
Antiproliferative activity against human IGROV1 cells assessed as growth inhibition after 72 hrs by Coulter counting analysis
Antiproliferative activity against human IGROV1 cells assessed as growth inhibition after 72 hrs by Coulter counting analysis
|
[PMID: 19833515] |
| KB | ED50 |
0.0018 μg/mL
Compound: 4
|
Cytotoxicity against human KB cells after 2 days
Cytotoxicity against human KB cells after 2 days
|
[PMID: 20542428] |
| L1210 | IC50 |
40 nM
Compound: 31
|
In vitro cytotoxicity against L1210 (murine leukemia) cells.
In vitro cytotoxicity against L1210 (murine leukemia) cells.
|
[PMID: 2299625] |
| LoVo | IC50 |
10.3 nM
Compound: DTCOLCH
|
Antiproliferative activity against human LoVo cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay
Antiproliferative activity against human LoVo cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay
|
[PMID: 34592435] |
| LoVo | IC50 |
1020 nM
Compound: 7
|
Cytotoxicity against human LoVo cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human LoVo cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30429975] |
| LoVo | IC50 |
16.9 nM
Compound: 3
|
Antiproliferative activity against human LoVo cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human LoVo cells incubated for 72 hrs by SRB assay
|
[PMID: 33465696] |
| MCF7 | GI50 |
0.018 μM
Compound: 11a
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell number incubated for 72 hrs
Antiproliferative activity against human MCF7 cells assessed as reduction in cell number incubated for 72 hrs
|
[PMID: 30996805] |
| MCF7 | IC50 |
14.2 nM
Compound: 3
|
Antiproliferative activity against human MCF-7 cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human MCF-7 cells incubated for 72 hrs by SRB assay
|
[PMID: 33465696] |
| MCF7 | IC50 |
4200 nM
Compound: 3
|
Anti tumor activity on human breast cancer cell line MDR-positive MCF-7 ADRr after 72 hours of treatment
Anti tumor activity on human breast cancer cell line MDR-positive MCF-7 ADRr after 72 hours of treatment
|
[PMID: 10602712] |
| MCF7 | IC50 |
670 nM
Compound: 7
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30429975] |
| MCF7 | IC50 |
9.5 nM
Compound: DTCOLCH
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by SRB assay
|
[PMID: 34592435] |
| MDA-MB-231 | IC50 |
1260 nM
Compound: 7
|
Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30429975] |
| MDA-MB-231 | IC50 |
2.2 nM
Compound: 3
|
Anti tumor activity on human breast cancer cell line MDR-negative MDA-MB 231 after 72 hours of treatment
Anti tumor activity on human breast cancer cell line MDR-negative MDA-MB 231 after 72 hours of treatment
|
[PMID: 10602712] |
| SK-BR-3 | ED50 |
0.0016 μg/mL
Compound: 4
|
Cytotoxicity against human SKBR3 cells after 2 days
Cytotoxicity against human SKBR3 cells after 2 days
|
[PMID: 20542428] |
| SK-OV-3 | IC50 |
1.3 nM
Compound: 7
|
Cytotoxicity against human SKOV3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human SKOV3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30429975] |
| SK-OV-3 | IC50 |
9.6 nM
Compound: 7
|
Cytotoxicity against arrested non-proliferative human SKOV3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against arrested non-proliferative human SKOV3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30429975] |
Chemical Information
-
CAS No. 2731-16-0
-
Molecular Weight 373.47
-
Formula C20H23NO4S
-
SMILES
COC1=C(C(C([C@@H](N)CC2)=C3)=CC=C(SC)C3=O)C2=CC(OC)=C1OC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Gelmi ML, et al. N-deacetyl-N-aminoacylthiocolchicine derivatives: synthesis and biological evaluation on MDR-positive and MDR-negative human cancer cell lines. J Med Chem. 1999 Dec 16;42(25):5272-6. [Content Brief]
[2]. Barešić M, et al. Different Therapeutic Paths (Colchicine vs. Anakinra) in Two Patients With Schnitzler's Syndrome. Arch Rheumatol. 2016 Jul 11;31(4):377-380. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)